NMPA Approval

Doxorubicin Hydrochloride Liposome Injection

Approval Number

国药准字H20123224

Company上海复旦张江生物医药股份有限公司

Registration Date

February 14, 2023

Drug Information

Generic Name

盐酸多柔比星脂质体注射液

Dosage Form

注射剂

Strength

5ml：10mg

Drug Type

化学药品

Registration Date

February 14, 2023

Company Information

Applicant Company

Company Name上海复旦张江生物医药股份有限公司

Company Address

上海市浦东新区张江高科技园区蔡伦路308号

Manufacturing Company

Company Name上海复旦张江生物医药股份有限公司

Company Address

上海市浦东新区张江高科技园区蔡伦路308号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸多柔比星脂质体注射液 - NMPA 批准文号 | MedPath